Sign In
Buy ADC
$72.03
-0.650 (-0.89%)
At Close: Jun 03, 2026
Tariffs Up, Inflation Down
09:00am, Sunday, 18'th May 2025
US equity markets surged this week - extending a dramatic post "Liberation Day" rebound - after the White House announced a trade truce with China, while investors cheered surprisingly cool inflation
The REIT Way To SWAN With These 5 Monthly Dividend Payers
07:00am, Saturday, 17'th May 2025
I highlight five SWAN (Sleep Well At Night) REITs that pay monthly dividends and offer strong balance sheets, attractive yields, and growth potential. Realty Income, Healthpeak, Agree Realty, LTC Prop
Buy The Dip: 2 Blue-Chip High Yields Getting Way Too Cheap
07:05am, Friday, 16'th May 2025
I focus on buying high-quality, high-yielding dividend growth stocks. When they go on sale, I pounce. I share two that are trading at highly compelling opportunities after recent pullbacks.
ADC Therapeutics to Present at Upcoming Investor Conferences
07:15am, Thursday, 15'th May 2025
LAUSANNE, Switzerland , May 15, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced par
Ideaya Biosciences: Value Beyond Darovasertib With ADC Program IDE849
05:30pm, Wednesday, 14'th May 2025
Ideaya Biosciences, Inc. is advancing darovasertib in a phase 2/3 trial for HLA-A2-negative metastatic uveal melanoma patients, with mPFS data expected by end of 2025. Ideaya plans a phase 3 study of
Agree Realty Announces Pricing of $400 Million of 5.600% Senior Unsecured Notes Due 2035
04:24pm, Wednesday, 14'th May 2025
Inclusive of Prior Hedging Activity the All-In Interest Rate of the Notes is 5.35% ROYAL OAK, Mich. , May 14, 2025 /PRNewswire/ -- Agree Realty Corporation (NYSE: ADC) (the "Company") today announced
ADC Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update
08:00am, Wednesday, 14'th May 2025
LOTIS-7 abstract accepted for presentation at the European Hematology Association 2025 Congress (EHA2025) and the 18th International Conference on Malignant Lymphoma (ICML); ZYNLONTA® plus glofitamab
ZYNLONTA ® plus glofitamab (COLUMVI®) demonstrated ORR of 95.5% and CR of 90.9%, among 22 evaluable patients with relapsed/refractory DLBCL Safety and tolerability data were consistent with the k
5 U.S. REITs Announce Dividend Increases In April
04:30am, Wednesday, 14'th May 2025
Five publicly traded real estate investment trusts in the US announced increases to their regular dividend payments in April, according to S&P Global Market Intelligence data. The total number of publ
Agree Realty Declares Monthly Common and Preferred Dividends
04:05pm, Tuesday, 13'th May 2025
ROYAL OAK, Mich. , May 13, 2025 /PRNewswire/ -- Agree Realty Corporation (NYSE: ADC) (the "Company") today announced that its Board of Directors has authorized, and the Company has declared, a monthly
Hard To Imagine Retirement Income Portfolio Without These 2 Picks
09:15am, Friday, 09'th May 2025
Typically, investors put a focus on high-yield securities if the goal is to live off from portfolio income streams. These high-yielding securities come from BDC, REIT, MLP, CEF and other value-oriente
Agree Realty: Premium Valuation, But Still Worth Considering
08:27am, Friday, 09'th May 2025
Agree Realty has outperformed peers and the S&P 500 since our last update, driven by a strong dividend yield and share price recovery. Even with the greater volatility that the broader market has been
A Ranking Of Net-Lease REITs By Investment Spread For Q1 2025
11:00am, Thursday, 08'th May 2025
In Q1 2025, VICI, GLPI, Agree, and Realty Income generated positive investment spreads and total returns exceeding their cost of equity, making them attractive investments. EPRT and STAG have negative
ADC Therapeutics to Host First Quarter 2025 Financial Results Conference Call on May 14, 2025
07:15am, Thursday, 08'th May 2025
LAUSANNE, Switzerland , May 8, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that
Correction Alert: Popular Dividend Growth Stocks Due For A Sharp Pullback
07:05am, Wednesday, 07'th May 2025
These 2 popular dividend growth stocks could decline by 10%+. Here's why we're avoiding them. I share two alternative peers that are more reasonably valued.
